Group | Age range (years) | Tumor grade | Myometrial invasion | Tumor maximum diameter (mm) | Lesion location | Treatment after surgery | Interval between initial surgery and recurrence(months) | Site of recurrence | Treatment after recurrence | Outcome | Observation time (months) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
50–55 | G1 | <50% | 20 | fundus | none | 60 | distant(lung involved) | chemotherapy | alive | 75 | ||
70–75 | G2 | <50% | 40 | diffuse lesion | none | 35 | distant(lung involved) | palliative treatment | died of recurrence | 66 | ||
LND | 50–55 | G1 | <50% | 20 | side wall | none | 12 | local | chemotherapy + radiotherapy | alive | 20 | |
n = 6 | 65–70 | G1 | <50% | 30 | left cornua | none | 38 | local | traditional Chinese medicine | alive | 41 | |
65–70 | G2 | <50% | 20 | side wall | none | 62 | local + distant | chemotherapy | died of recurrence | 126 | ||
60–65 | G1 | <50% | 26 | left cornua | none | 23 | local | radiotherapy | alive | 48 | ||
65–70 | G2 | <50% | 25 | side wall | none | 57 | local + distant | unknown | died of recurrence | 57 | ||
50–55 | G1 | <50% | 25 | side wall | chemotherapy + radiotherapy | 5 | local | radiotherapy | alive | 85 | ||
50–55 | G1 | <50% | 32 | side wall | none | 25 | local | radiotherapy | alive | 66 | ||
LND omitted | 65–70 | G1 | <50% | 24 | fundus | none | 34 | distant | surgery | alive | 47 | |
n = 9 | 55–60 | G1 | <50% | 20 | left cornua | none | 8 | local | surgery + chemotherapy | alive | 76 | |
55–60 | G1 | <50% | 50 | side wall | chemotherapy | 12 | distant(lung involved) | chemotherapy | alive | 49 | ||
45–50 | G1 | <50% | 22 | lower uterine segment | chemotherapy | 12 | distant | chemotherapy | died of recurrence | 99 | ||
65–70 | G2 | <50% | 30 | side wall | none | 8 | distant | chemotherapy | died of recurrence | 43 | ||
65–70 | G2 | none | 50 | right cornua | none | 7 | distant | chemotherapy | died of recurrence | 30 |